| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/24/2001 | US6221898 Anticoagulants |
| 04/24/2001 | US6221894 Nodulisporic acid derivatives |
| 04/24/2001 | US6221893 Administration of histamine for therapeutic purposes |
| 04/24/2001 | US6221892 Heterocyclic topoisomerase poisons |
| 04/24/2001 | US6221891 Crystal form of N-(4-triflouromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/24/2001 | US6221889 Interleukin antagonist; skin disorders, respiratory system disorders, rheumatic disorders |
| 04/24/2001 | US6221887 Treatment of inflammatory disorders with NMDA antagonists and sodium channel antagonists |
| 04/24/2001 | US6221886 Thio acid derived monocyclic N-heterocyclics as anticoagulants |
| 04/24/2001 | US6221883 Method of dopamine inhibition using l-threo-methylphenidate |
| 04/24/2001 | US6221882 Administration of specific compounds of the general class of 4-aminoquiniolines; inhibiting immunostimulatory dna-associated antiapoptotic effects |
| 04/24/2001 | US6221881 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 04/24/2001 | US6221880 In combination antagonists of neurokinin receptors and antagonists of leukotriene receptors |
| 04/24/2001 | US6221879 8-azabicyclo[3.2.1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors |
| 04/24/2001 | US6221878 Antagonists of 5-hydroxytryptamine (5-ht) at 5-ht3 receptors |
| 04/24/2001 | US6221877 In particular bovine trichomoniasis and giardiasis |
| 04/24/2001 | US6221876 190 kda multidrug resistance protein (mrp1); 1-amino-2-hydroxyindan-6-yl)isoxazolo(3, 4-c)-1,2-dihydro-3-methyl-6-chloroquinolin-2-one derivatives |
| 04/24/2001 | US6221874 Method of treating bone loss by stimulation of calcitonin |
| 04/24/2001 | US6221873 Cyclin dependent kinase inhibitor |
| 04/24/2001 | US6221870 Treatment of depression, anxiety, bipolar disorders and adhd |
| 04/24/2001 | US6221867 4,5-pyrazinoxindoles |
| 04/24/2001 | US6221866 Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament, and pharmaceutical formulations containing them |
| 04/24/2001 | US6221864 Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters |
| 04/24/2001 | US6221863 Treating depression in a patient |
| 04/24/2001 | US6221861 Reducing pyrophosphate deposition with calcium antagonists |
| 04/24/2001 | US6221860 Beta-lactam inhibitors of CoA-IT |
| 04/24/2001 | US6221859 Carbapenem antibacterial compositions and methods of the treatment |
| 04/24/2001 | US6221858 Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders |
| 04/24/2001 | US6221857 Altering sex ratio of offspring in mammals |
| 04/24/2001 | US6221856 Inositol derivatives for inhibiting superoxide anion production |
| 04/24/2001 | US6221854 Method of promoting bone growth with hyaluronic acid and growth factors |
| 04/24/2001 | US6221853 Mixture of pharmaceutically acceptable purified paraffinic hydrocarbons, this vehicle having a melting point of about 37 degrees c.+-4 degrees c. |
| 04/24/2001 | US6221852 Pharmaceutical compositions of 5-alkynyl-dideoxyribouracil |
| 04/24/2001 | US6221851 Increasing cellular availability of adenosine. |
| 04/24/2001 | US6221850 For detecting and modulating levels of jun n-terminal kinases (jnk proteins), enzymes which are encoded by jnk genes. |
| 04/24/2001 | US6221849 Inhibiting tumor growth |
| 04/24/2001 | US6221844 Texenomycins having a specific amino acid sequence |
| 04/24/2001 | US6221842 Method of treating muscular disorders |
| 04/24/2001 | US6221840 Intestinal trefoil proteins |
| 04/24/2001 | US6221836 Composition of pyruvate and anabolic protein and method for increasing fat loss in a mammal |
| 04/24/2001 | US6221667 Packaged pharmaceutical composition includes a mobile ionophore which prevents or decreases amyloid precursor protein catabolism in cells without altering cell viability in a pharmaceutical vehicle in a container, and instructions |
| 04/24/2001 | US6221664 Composite vaccine which contains antigen, antibody and recombinant DNA and its preparing method |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221628 Nucleotide sequences coding preferential polypeptide for use in diagnosis and treatment atherosclerosis, ischemia, hypertension, restenosis and arterial inflammation |
| 04/24/2001 | US6221618 Detection of modulators which suppresses cardiovascular disorders; incubate heart muscle cells with inducer of cardiovascular disorders, measure development of hypertrophy |
| 04/24/2001 | US6221616 Detecting modulators of receptor binding protein; incubate cells with modulators and monitoring reduction in binding activity at receptor |
| 04/24/2001 | US6221613 Utilizing competitive binding to detect preferential modulator activity on receptor binding protein; incubate cells with modulators and monitor binding, detect amplification or reduction of binding to receptors |
| 04/24/2001 | US6221425 Lubricious hydrophilic coating for an intracorporeal medical device |
| 04/24/2001 | US6221400 Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors |
| 04/24/2001 | US6221396 Oral cisapride dosage forms with an extended duration |
| 04/24/2001 | US6221395 Controlled release pharmaceutical tablets containing an active principle of low water solubility |
| 04/24/2001 | US6221394 In one portion thereof, substantially single (+)-tramadol, and, in another separate portion thereof, substantially single (-)-tramadol; the different tramadol enantiomers are released at different rates from the dosage form. |
| 04/24/2001 | US6221391 Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith |
| 04/24/2001 | US6221385 Freeze dried liposome encapsulated amphiphilic drug compositions and a process for the preparation thereof |
| 04/24/2001 | US6221379 Buccal drug administration in female hormone replacement therapy |
| 04/24/2001 | US6221377 Administration media for analgesic, anti-inflammatory and anti-pyretic drugs containing nitrous oxide and pharmaceutical compositions containing such media and drugs |
| 04/24/2001 | US6221376 Glial cell line-derived neurotrophic factor |
| 04/24/2001 | US6221371 Pseudoceramides, and dermatologic external preparations containing the same |
| 04/24/2001 | US6221367 Exposing a biologically active agent to a complexing perturbant to reversibly transform the biologically active agent to the intermediate state and to form a transportable supramolecular complex |
| 04/24/2001 | US6221357 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor |
| 04/24/2001 | US6221350 Enhancement of microbial colonisation of the gastrointestinal tract |
| 04/24/2001 | US6221339 Medicaments |
| 04/24/2001 | US6221334 Polyaza macrocyclic ligands chelated to superparamagnetic or paramagnetic metals and coupled to folate-receptor binding ligands through the gamma carboxylate of folate |
| 04/24/2001 | US6221153 Dissolving compound selected from taxoid or brystatin in solvent; mixing with critical, supercritical or near critical fluid to form solution comprising fluid solvent and compound; precipitating compound as needle like crystal |
| 04/24/2001 | CA2222976C Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
| 04/24/2001 | CA2220055C Dipeptides which promote release of growth hormone |
| 04/24/2001 | CA2188703C Therapeutic injectable analgesic pharmaceutical composition containing nimesulide 4-nitro, 2-phenoxyphenyl methane sulphonamide for intramuscular administration |
| 04/24/2001 | CA2166203C Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]- 6-chloro-1,3-dihydro-indol-2-one |
| 04/24/2001 | CA2165192C Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 04/24/2001 | CA2101164C Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 04/24/2001 | CA2085885C Alteration of rate and character of hair growth |
| 04/24/2001 | CA2078520C Trimetazidine derivatives, process for preparing same and pharmaceutical compositions containing same |
| 04/24/2001 | CA2073166C Process to correct and optimize the composition of a feed |
| 04/24/2001 | CA2061101C Use of tba as a drug against stress in aquaculture |
| 04/24/2001 | CA2053277C Use of lipoxin a4 and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 04/24/2001 | CA2046397C Inflammatory bowel disease preventive and curative agents containing zinc l- carnosine salt or complex as active ingredient |
| 04/24/2001 | CA2041400C Preparation of a medicament |
| 04/24/2001 | CA2032233C Pour-on formulations effective for the control of internal and external parasites of homothermic animals |
| 04/24/2001 | CA2030459C Biodegradable ocular implants |
| 04/24/2001 | CA2027630C Protein gel ophthalmic vehicle |
| 04/24/2001 | CA2025326C Nmda antagonists |
| 04/24/2001 | CA2021881C Process for preparing lankacidine carbamate derivatives |
| 04/19/2001 | WO2001027314A1 Antiprotozoal histone acetyl transferase inhibitors |
| 04/19/2001 | WO2001027309A1 Hiv integrase inhibitors |
| 04/19/2001 | WO2001027305A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | WO2001027304A2 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 04/19/2001 | WO2001027290A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027280A1 Antimicrobial compositions |
| 04/19/2001 | WO2001027273A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027267A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 04/19/2001 | WO2001027265A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/19/2001 | WO2001027263A1 Modulate aptamer and method for detecting target protein by using the same |
| 04/19/2001 | WO2001027262A1 Gene selection using pnas |
| 04/19/2001 | WO2001027152A1 Method of altering polypeptide aggregation |
| 04/19/2001 | WO2001027149A1 Human cervical cancer 1 protooncogene and protein encoded therein |
| 04/19/2001 | WO2001027135A2 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 04/19/2001 | WO2001027132A1 Estradiol conjugates and uses thereof |
| 04/19/2001 | WO2001027131A1 Purine derivatives |
| 04/19/2001 | WO2001027130A1 Purine derivatives |
| 04/19/2001 | WO2001027128A1 C-aryl glucoside sglt2 inhibitors |